The posterior cerebellum, a new organ at risk?
- PMID: 29594239
- PMCID: PMC5862675
- DOI: 10.1016/j.ctro.2017.11.010
The posterior cerebellum, a new organ at risk?
Abstract
Eekers et al. have recently proposed a neuro-oncology atlas, which was co-authored by most centers associated in the European Proton Therapy Network (EPTN; Figure 1). With the introduction of new treatment techniques, such as integrated magnetic resonance imaging and linear accelerators (MR-linac) or particle therapy, the prediction of clinical efficacy of these more costly treatment modalities becomes more relevant. One of the side-effects of brain irradiation, being cognitive decline, is one of the toxicities most difficult to measure and predict. In order to validly compare different treatment modalities, 1) a uniform nomenclature of the organs at risk (OARs), 2) uniform atlas-based delineation [e.g., Eekers et al.], 3) long-term follow-up data with standardized cognitive tests, 4) a large patient population, and 5) (thus derived) validated normal tissue complication probability (NTCP) models are mandatory. Apart from the Gondi model, in which the role of the dose to 40% of both hippocampi (HC) proves to be significantly related to cognition in 18 patients, no similar models are available. So there is a strong need for more NTCP models, on HC, brain tissue and possible other relevant brain structures. In this review we summarize the available evidence on the role of the posterior cerebellum as a possible new organ at risk for cognition, which is deemed relevant for irradiation of brain and head and neck tumors.
Keywords: Cognition; Delineation atlas; Neuro-oncology; Organ at risk; Posterior cerebellum; Radiotherapy.
Figures
References
-
- Eekers DBP, in ’t Ven L, Roelofs E, Postma A, Alapetite C, Burnet N, et al. The EPTN consensus-based atlas for CT- and MR-based contouring in Neuro-Oncology. Submitted. - PubMed
-
- Gondi V., Hermann B.P., Mehta M.P., Tomé W.A. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys. 2013;85(2):348–354. - PubMed
-
- Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010;36(4):277–285. - PubMed
-
- Habrand J.L., De Crevoisier R. Radiation therapy in the management of childhood brain tumors. Childs Nerv Syst. 2001;17(3):121–133. - PubMed
-
- Ribi K., Relly C., Landolt M.A., Alber F.D., Boltshauser E., Grotzer M.A. Outcome of medulloblastoma in children: long-term complications and quality of life. Neuropediatrics. 2005;36(6):357–365. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
